NAD+ 500MG
3-PEPTIDE RESEARCH BLEND
GLOW 70MG
Research Blends, Research Peptide Pens, Skin and Copper-Peptide Research
One pre-filled 70mg GLOW research pen combining GHK-Cu 50mg, BPC-157 10mg and TB-500 10mg.
£159.00Free UK tracked delivery
Compare recovery optionsBPC-157, TB-500, Wolverine, GLOW and KLOW→
- Made fresh to order
- Batch documentation pending
- UK tracked delivery
- Order by 1pm on working days for same-day dispatch
- Results published when verified
Research Use Only
GLOW 70mg is a three-peptide research blend of GHK-Cu, BPC-157 and TB-500, supplied in one pre-filled research pen. Each pen contains GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. Every GLOW blend is prepared to order in the UK and shipped cold chain by tracked delivery.
Each of the three compounds has its own published preclinical literature. Laboratories use multi-peptide blends to study how separate signalling pathways behave within the same in-vitro or animal model. GLOW is also the base of our four-peptide KLOW blend, which adds KPV. Read KLOW vs GLOW for the differences, or peptide stacks explained for background.
Blend composition
| GHK-Cu | 50 mg · Copper-binding tripeptide (Gly-His-Lys:Cu²⁺) |
|---|---|
| BPC-157 | 10 mg · Synthetic 15-amino-acid peptide |
| TB-500 | 10 mg · Synthetic thymosin beta-4 fragment (Ac-LKKTETQ) |
| Total | 70 mg in one pre-filled research pen |
How each component is studied
The three peptides in GLOW act through different pathways in laboratory studies:
- GHK-Cu is a naturally occurring copper-binding tripeptide. Fibroblast and gene-expression studies link it to collagen production, extracellular-matrix remodelling and many other cellular pathways.
- BPC-157 is a stable 15-amino-acid sequence derived from a gastric protein. Animal and cell studies have examined it in models of blood-vessel growth and tendon fibroblast migration.
- TB-500 is a synthetic seven-amino-acid fragment of thymosin beta-4 (Ac-LKKTETQ), the region of the protein that binds actin. The fragment and the full protein are studied in models of cell migration and new blood-vessel formation.
5 key research areas
- Angiogenesis and vascular signalling. BPC-157 and thymosin beta-4 have both been examined in animal models of blood-vessel growth.
- Cell migration and actin dynamics. Thymosin beta-4 and its LKKTETQ motif bind actin in cells. BPC-157 has been studied for its effect on how tendon fibroblasts spread and migrate.
- Extracellular matrix and gene expression. GHK-Cu studies cover collagen synthesis in fibroblast cultures and large-scale gene-expression data.
- Cardiac cell models. In mice, thymosin beta-4 activated integrin-linked kinase and was studied for its effect on cardiomyocyte migration and survival.
- Skin and connective-tissue models. All three compounds appear in preclinical work on skin wound, tendon and connective-tissue models.
Selected published research
Peer-reviewed studies and reviews on each GLOW component, with PubMed IDs:
- Seiwerth S, et al. (2021). Stable gastric pentadecapeptide BPC 157 and wound healing. Frontiers in Pharmacology. PMID 34267654
- Chang CH, et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. PMID 21030672
- Malinda KM, et al. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology. PMID 10469335
- Bock-Marquette I, et al. (2004). Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. PMID 15565145
- Goldstein AL, et al. (2012). Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy. PMID 22074294
- Maquart FX, et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. PMID 3169264
- Pickart L, Margolina A (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. PMID 29986520
These references describe laboratory and animal research on the individual compounds. None of them studied the GLOW blend, and none is evidence of safety or effect in humans.
Why a single-batch blend
- All three compounds come from one batch, under one batch reference
- One Certificate of Analysis will cover the whole blend once independent testing is complete
- Fewer handling steps than preparing three separate compounds
- Consistent composition from one order to the next
What arrives
70mg blend pen
One pre-filled Apexion research pen
One pre-filled Apexion research pen
Three-compound blend
GHK-Cu, BPC-157 and TB-500
GHK-Cu, BPC-157 and TB-500
Protected packaging
Discreet and tamper-evident
Discreet and tamper-evident
Batch traceability
Batch number on every pen; independent testing in progress
Batch number on every pen; independent testing in progress
Preparation and UK dispatch
- Made fresh to order after checkout
- Prepared and quality checked before dispatch
- Tracked Royal Mail delivery across the UK
- UK-based product and documentation support
Simple, secure checkout
Pay by Bank is the preferred option
Card payments are temporarily unavailable.
Card payments are temporarily unavailable.
Independent testing is in progress; results will be published only when verified evidence is available.
Research use only. GLOW is supplied for in-vitro laboratory research by qualified researchers. It is not a medicine, is not licensed by the MHRA, and is not intended for human or veterinary use, diagnosis or treatment.
| Content | 70 mg total, one pre-filled research pen |
|---|---|
| Purity | Independent testing in progress; results published on verification |
| Active ingredient | GHK-Cu 50 mg · BPC-157 10 mg · TB-500 10 mg |
| CAS | 89030-95-5 (GHK-Cu) / 137525-51-0 (BPC-157) / not assigned (TB-500 fragment) |
| Molecular formula | C14H22CuN6O4 / C62H98N16O22 / C38H68N10O14 |
| Molecular weight | ~401.9 / ~1419.5 / ~889.0 g/mol |
| Form | Pre-filled research pen (three-peptide blend) |
| Origin | UK-stocked, tracked Royal Mail dispatch |
| Intended use | Laboratory research only. Not for human consumption. |
Every GLOW pen is made fresh after your order is placed, and each one is prepared and quality checked before dispatch. Independent third-party testing of the blend is under way. The batch Certificate of Analysis will be published here, and linked to your pen's batch number, as soon as results are verified. Read how we test and verify every batch on our Quality & Batch Verification page.
| Documentation status | Independent testing in progress |
|---|---|
| Test method | HPLC (purity and identity) |
| Analysis | Independent third-party laboratory, plus in-house QC on every pen |
| Verification | Batch number on every pen; COA linked by QR once published |
Storage conditions
- Shipped cold chain to keep the pen cool in transit
- Long-term: −20 °C in a temperature-controlled environment
- Short-term: keep cool and stable (2–8 °C) and away from direct light
- Keep the pen sealed when not in use
- Avoid repeated temperature changes (freeze–thaw cycles)
Handling guidance
- Check that the packaging and tamper seal are intact on arrival
- Handle as little as possible, using standard laboratory practice
- Record the batch number for traceability
- Follow any batch-specific guidance supplied with your order
What is the GLOW peptide blend?
GLOW is a three-peptide research blend of GHK-Cu, BPC-157 and TB-500, supplied as 70 mg in one pre-filled research pen. Each compound has its own published preclinical literature. It is for laboratory research only.
What is the difference between GLOW and KLOW?
GLOW combines three peptides: GHK-Cu, BPC-157 and TB-500. KLOW adds a fourth, KPV, a tripeptide fragment of alpha-MSH that is studied in inflammatory-signalling models. Both are supplied for research use only.
What ratio is used in GLOW 70mg?
Each pen contains GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, for 70 mg in total. All three compounds come from one batch under one batch reference.
Is GLOW independently tested?
Every GLOW pen is made fresh after your order is placed, so each one is prepared and quality checked to order rather than taken from old stock. Independent third-party testing of the blend is under way, and the batch Certificate of Analysis will be published as soon as the results are verified. Each pen carries a batch number, so its documentation can be traced.
Can GLOW be used in humans or animals?
No. GLOW is not a medicine and is not licensed by the MHRA. It is supplied strictly for in-vitro laboratory research, and is not for human or veterinary use, diagnosis or treatment.
How should GLOW be stored?
GLOW is shipped cold chain. On arrival, keep the pen sealed and store it at −20 °C for long-term storage, away from heat and direct light. Handle it as little as possible and follow any batch-specific guidance supplied with your order.
Upsell
Frequently bought together
Bundle price
£288.99
£308.99
Save £20.00
Compare
Compare with KLOW 80MG
| This product GLOW 70MG | KLOW 80MG | |
|---|---|---|
| Contents | 70 mg total, one pre-filled research pen | 80 mg total, one pre-filled research pen |
| Compounds | GHK-Cu 50 mg · BPC-157 10 mg · TB-500 10 mg | GHK-Cu 50 mg · BPC-157 10 mg · TB-500 10 mg · KPV 10 mg |
| Format | Pre-filled research pen (three-peptide blend) | Pre-filled research pen (four-peptide blend) |
| Price | £159.00 | £175.00 |
| Price per mg | £2.27 | £2.19 |
| Independent testing | Independent testing in progress | Independent testing in progress |
| View KLOW 80MG |
Price per mg is the price divided by the total labelled contents. For laboratory research use only.
Cross-sell
